3AQ-11362-99466
2 vaccinations
10 coded responses
24 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 996 / AK
- Registered
- 2021-05-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-10
Registered in v-safe
-
2021-05-10
Dose 1 — Janssen/Johnson & Johnson
-
2021-05-10
Survey response — day 0, dose 1MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to workFree text: Many of these are symptoms common to my chronic health challengesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Pre-existing disease, Rash — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Rash is consistent with a flare of my usual chronic health conditionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-13
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue, Pre-existing disease — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: All above symptoms are consistent with my chronic health challenges. In hindsight, the first two days were likely reaction to the vaccine. Hard to tell if the lingering fatigue is it or not.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Symptoms consistent with chronic health challengesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Health check-in — day 7, dose 1Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-24
- 2021-06-02
-
2021-06-09
Survey response — day 28, single doseMedDRA: Arthralgia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Increased joint pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-15
Survey response — day 35, single doseMedDRA: Arthralgia, Fatigue, Somnolence — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Continuing increased joint pain, and also significant fatigue/daytime sleepinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-21
- 2021-08-11
- 2021-11-11
-
2021-12-17
Dose 2 — Moderna
-
2021-12-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body achesAdult check-in
-
2021-12-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-21
Survey response — days 1–6 daily, dose 2MedDRA: Balance disorder, Vertigo — Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Increased vertigo/disequilibriumMedDRA releases: 2024-11 · check-in free text available
-
2021-12-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
-
2021-12-24
Health check-in — day 7, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-31
Survey response — day 14, dose 2MedDRA: Headache — Feeling: Fair · Be unable to work or attend schoolFree text: Continuing to experience mild to moderate daily headaches.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Survey response — day 21, dose 2MedDRA: Headache — Feeling: FairFree text: Daily headachesMedDRA releases: 2024-11 · check-in free text available
- 2022-01-14
-
2022-01-29
Survey response — day 42, dose 2MedDRA: Cough, Exposure to SARS-CoV-2, Fatigue, Headache, Oropharyngeal pain, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fatigue, headache, cough, sore throat, body aches. All but fatigue are mild after close contact exposure to COVID positive friends.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-10 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-17 | Moderna | No |
Free text
Release 8 — day 0, dose 1
Systemic reaction (other): Many of these are symptoms common to my chronic health challenges
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Rash is consistent with a flare of my usual chronic health condition
Systemic reaction (other): All above symptoms are consistent with my chronic health challenges. In hindsight, the first two days were likely reaction to the vaccine. Hard to tell if the lingering fatigue is it or not.
Systemic reaction (other): Symptoms consistent with chronic health challenges
Release 9 — day 28, single dose
Symptoms: Increased joint pain.
Release 9 — day 35, single dose
Symptoms: Continuing increased joint pain, and also significant fatigue/daytime sleepiness
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Increased vertigo/disequilibrium
Release 10 — day 14, dose 2
Symptoms: Continuing to experience mild to moderate daily headaches.
Release 10 — day 21, dose 2
Symptoms: Daily headaches
Release 11 — day 42, dose 2
Symptoms: Fatigue, headache, cough, sore throat, body aches. All but fatigue are mild after close contact exposure to COVID positive friends.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Somnolence | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Balance disorder | · | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release